Some types of polyps can change into cancer over time (usually many years), but not all polyps become cancer. The chance of a polyp changing into cancer depends on the type of polyp it is. The 2 main types of polyps are:
Adenomatous polyps (adenomas): These polyps sometimes change into cancer. Because of this, adenomas are called a pre-cancerous condition.
q Hyperplastic polyps and inflammatory polyps: These polyps are more common, but in general they are not pre-cancerous. Other factors that can make a polyp more likely to contain cancer or increase someone's risk of developing colorectal cancer include:
If a polyp larger than 1 cm is found q If more than 2 polyps are found q If dysplasia is seen in the polyp after it's removed. Dysplasia is another precancerous condition. It means there's an area in a polyp or in the lining of the colon or rectum where the cells look abnormal, but they don't look like true cancer cells. q For more details on the types of polyps and conditions that can lead to colorectal cancer, see Understanding Your Pathology Report: Colon Polyps 2 .
How colorectal cancer spreads
If cancer forms in a polyp, it can grow into the wall of the colon or rectum over time. The wall of the colon and rectum is made up of many layers. Colorectal cancer starts in the innermost layer (the mucosa) and can grow outward through some or all of the other layers.
When cancer cells are in the wall, they can then grow into blood vessels or lymph vessels (tiny channels that carry away waste and fluid). From there, they can travel to nearby lymph nodes or to distant parts of the body.
The stage (extent of spread) of a colorectal cancer depends on how deeply it grows into the wall and if it has spread outside the colon or rectum. For more on staging, see Colorectal Cancer Stages 3 .
Where does colorectal cancer grow?
To understand colorectal cancer, it helps to understand the parts that make up the colon and rectum. The colon and rectum make up the large intestine (or large bowel), which is part of the digestive system, also called the gastrointestinal (GI) system (see illustration below).
Most of the large intestine is made up of the colon, a muscular tube about 5 feet long. The parts of the colon are named by which way the food is traveling through them.
The first section is called the ascending colon. It starts with a pouch called the cecum, where undigested food is comes in from the small intestine. It extends upward on the right side of the abdomen (belly). The third section is called the descending colon because it descends (travels down) on the left side. The fourth section is called the sigmoid colon because of its "S" shape. The sigmoid colon joins the rectum, which connects to the anus. 
What do the colon and rectum do?
The colon absorbs water and salt from the remaining food matter after it goes through the small intestine (small bowel). The waste matter that's left after going through the colon goes into the rectum, the final 6 inches of the digestive system. It's stored there until it passes out of the body through the anus. Ring-shaped sphincter (SFINK-ter) muscles around the anus keeps stool from coming out until they relax during a bowel movement.
Types of cancer in the colon and rectum
Adenocarcinomas make up about 96% of colorectal cancers. These cancers start in cells that make mucus to lubricate the inside of the colon and rectum. When doctors talk about colorectal cancer, they're almost always talking about this type. Some sub-types of adenocarcinoma, such as signet ring and mucinous, may have a worse prognosis ____________________________________________________________________________________ (outlook).
Other, much less common types of tumors can start in the colon and rectum, too. These include:
Carcinoid tumors. These start from special hormone-making cells in the intestine. 
Deaths from colorectal cancer
In the United States, colorectal cancer is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. It's expected to cause about 53,200 deaths during 2020
The death rate (the number of deaths per 100,000 people per year) from colorectal cancer has been dropping in both men and women for several decades. There are a number of likely reasons for this. One is that colorectal polyps are now being found more often by screening 2 and removed before they can develop into cancers or are being found earlier when the disease is easier to treat. In addition, treatment for colorectal cancer has improved over the last few decades. As a result, there are now more than 1 million survivors of colorectal cancer in the United States. Although the overall death rate has continued to drop, deaths from colorectal cancer among people younger than age 55 have increased 2% per year from 2007 and 2016. 
What's New in Colorectal Cancer Research?
Research is always going on in the area of colorectal cancer. Scientists are looking for causes and ways to prevent colorectal cancer, better ways to find it early (when it's small and easier to treat), and ways to improve treatments. Here are some examples of current research. Treatment in a clinical trial 1 is often the only way to get these treatments.
Reducing colorectal cancer risk
Many studies are looking to identify the causes of colorectal cancer 2 . The hope is that this might lead to new ways to help prevent it.
Other studies are looking to see if certain types of diets, dietary supplements, or medicines can lower a person's risk of colorectal cancer. For example, many studies have shown that aspirin and pain relievers like it might help lower the risk of colorectal cancer, but these drugs can have serious side effects. Researchers are now trying to figure out if the benefits might outweigh the risks for certain groups of people thought to be at high colorectal cancer risk.
Early detection
Doctors are looking for better ways to find colorectal cancer early 3 by studying new types of screening tests (like blood tests) and improving the ones already being used. Researchers are also trying to figure out if there's any test or screening plan that clearly works best.
They're also looking for ways to educate and encourage people to get the routine screening tests 4 that are available today and known to help reduce the number of deaths from this cancer.
Diagnosis
Researchers are trying to define colorectal cancer sub-types. This means grouping colorectal cancers based on things like the genetic mutations in the cancer cells, how the cells look and behave, how fast the cells are dividing, and features of the tumor itself. As has been found with other cancer types, this might lead to better understanding of disease progression and outcomes, as well as more clearly defined treatment plans (precision medicine).
Lab tests to help plan treatment
Lab tests have been developed to help predict which patients have a higher risk of colorectal cancer recurrence (the cancer coming back after treatment). These tests look at different genes inside the person's colorectal cancer cells. These tests are being studied to see if they might help decide which treatment plan is best for each person. They might also be helpful in deciding if more treatment is needed after surgery.
As doctors continue to learn more about the genetic changes in colorectal cancer cells, they're also looking for better ways to predict outcomes and adjust treatment plans for each patient. Early studies have already shown that certain cancer cell changes can affect the response to certain chemo drugs, but more research is needed. Identifying changes that are only found in the cancer cells could also lead to better screening tests that look for these specific changes.
Treatment
Researchers are always looking for better ways to treat colorectal cancer.
Surgery
Surgeons continue to improve the operations used for colorectal cancers 5 . Research looking at the benefits of laparoscopic and robotic 6 surgeries compared to open surgeries (where bigger cuts are made in the skin) is common. Rectal cancer surgery done through the anus 7 , without cutting the skin, is also being studied.
Organ preservation --keeping your body working the way it normally does --is another research goal. For instance:
Doctors are looking at the ideal timing of surgery after chemo is used to shrink a rectal tumor and how to know when they've got the best response in each patient.
q Studies are also looking for better ways to reattach the ends of the colon after the length with the tumor has been removed.
q Surgery that saves the anal sphincter muscle that controls the passing of stool is a rectal cancer research interest.
q Sometimes when colorectal cancer recurs (comes back), it spreads to the peritoneum (the thin lining of the abdominal cavity and organs inside the abdomen). These cancers are often hard to treat. Surgeons have been studying a procedure called hyperthermic intraperitoneal chemotherapy (HIPEC). First, surgery is done to remove as much of the cancer in the belly as possible. Then, while still in the operating room, the abdominal cavity is bathed in heated chemotherapy drugs. This puts the chemo right into contact with the cancer cells, and the heat is thought to help the drugs work better. Some patients are living longer with this type of treatment, but more studies are needed to know which patients it can help. Doctors and nurses with special training and specialized equipment are needed, so it's not widely available.
Chemotherapy
Chemotherapy 8 is an important part of treatment for many people with colorectal cancer, and doctors are constantly trying to make it more effective and safer. Different approaches are being tested in clinical trials, including:
Testing new chemo drugs or drugs that are already used against other cancers. Studying the best ways to combine chemotherapy with radiation therapy, targeted therapies, and/or immunotherapy.
q Better ways to identify, prevent, and treat chemo side effects 9 are other areas of research interest.
Targeted therapy
Targeted therapy 10 drugs work differently from standard chemotherapy drugs. They affect specific parts of cancer cells that make them different from normal cells. Several targeted therapy drugs 11 are already used to treat advanced colorectal cancer. Researchers are studying the best way to give these drugs and looking for new targeted therapy drugs. Studies are also looking at colorectal cancer cells to try to find specific gene changes (mutations) that might be targeted as part of treatment.
Studies are being done to see if using targeted therapy along with chemotherapy in earlier-stage cancers can help reduce the risk of recurrence.
Immunotherapy
An exciting area of research is the field of immunotherapy 12 . This is treatment that uses the body's own immune system to fight cancer.
Immune checkpoint inhibitors:
An important part of the immune system is its ability to tell between normal cells in the body and those it sees as "foreign." This lets the immune system attack the foreign cells while leaving the normal cells alone. To do this, it uses "checkpoint" proteins on certain immune cells. These proteins act like switches, needing to be turned on (or off) to start an immune response. Cancer cells sometimes use these checkpoints to keep from being attacked by the immune system. Newer drugs that target checkpoint proteins hold a lot of promise as cancer treatments. Colorectal cancer cells that have specific gene changes, such as high levels of microsatellite instability (MSI-H), or changes in one of the mismatch repair (MMR) genes, tend to have a lot of other changes that make them different from normal colorectal cells. This might make them more visible to the immune system. Studies are looking at whether cancers with these changes are being helped by treatment with new drugs that focus on these cell changes.
Cancer vaccines: Researchers are studying several vaccines to try to treat colorectal cancer or keep it from coming back after treatment. Unlike vaccines that prevent infectious diseases, these vaccines are meant to boost the person's immune system to better find and fight colorectal cancer cells.
Many types of vaccines are being studied. For example, some vaccines are created by removing some of the person's own immune system cells (called dendritic cells) from the tumor, treating them with a substance that will help them find and attack cancer cells, and then putting them back into the person's body.
